INmune Bio Inc. (INMB)
NASDAQ: INMB
· Real-Time Price · USD
7.33
-0.10 (-1.35%)
At close: May 15, 2025, 3:59 PM
7.30
-0.41%
After-hours: May 15, 2025, 07:52 PM EDT
-1.35% (1D)
| Bid | 7.1 |
| Market Cap | 170.13M |
| Revenue (ttm) | 50K |
| Net Income (ttm) | -40.8M |
| EPS (ttm) | -1.93 |
| PE Ratio (ttm) | -3.8 |
| Forward PE | -4.75 |
| Analyst | Buy |
| Ask | 8.5 |
| Volume | 179,467 |
| Avg. Volume (20D) | 258,098 |
| Open | 7.40 |
| Previous Close | 7.43 |
| Day's Range | 7.19 - 7.53 |
| 52-Week Range | 4.32 - 11.46 |
| Beta | 1.64 |
About INMB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol INMB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for INMB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+10.67%
Inmune Bio shares are trading higher after the com...
Unlock content with
Pro Subscription
6 months ago
+13.84%
INmune Bio shares are trading higher after the company announced it will host a webinar on cognitive testing using EMACC and CDR-SB on November 7 at 1 pm ET.
22 hours ago · seekingalpha.com
INmune Bio: XPro Trial Readout In Alzheimer's Disease Offers Big OpportunityI rate INmune Bio, Inc. a speculative Strong Buy for high-risk investors, hinging on XPro's upcoming Phase II results in early Alzheimer's disease. XPro's unique mechanism targets neuroinflammation wi...
1 month ago · seekingalpha.com
Undercovered Dozen: INmune Bio, Primerica, First Quantum, Pinnacle West +The 'Undercovered' Dozen series highlights 12 lesser-covered stocks, offering fresh ideas and fostering discussion among investors. Mitsui & Co. is given a 'buy' recommendation, driven by Warren Buffe...
